Hilary Pinnock, MD, talks about what her session at the European Respiratory Society International Congress 2021 will cover and other sessions that she's excited to check out.
Hilary Pinnock, MD, talks about what her session at the European Respiratory Society International Congress 2021 will cover and other sessions that she's excited to check out.
Transcript:
What is your session going to cover?
So, this is part of a symposium which is looking at how our delivery of care may have changed as a result of the COVID-19 pandemic. And one aspect of that, clearly during the pandemic, has been a huge shift to remote consulting. And what we wanted to consider was the implications of that, what evidence we have for these different types of consultations, and whether we're perhaps going to continue to do that or whether it's just something we did during the pandemic and how this is going to shape future consulting.
So, I've done a bit of work in the past about remote consultations, particularly telephone consultations for people reviewing people with asthma, which is hence my interest in the topic.
What other sessions are you looking forward to hearing about?
There are sessions set up by the primary care group within the assembly. Again, they're looking at how we are going to be diagnosing and managing, particularly asthma and COPD [chronic obstructive pulmonary disease] in the future, because again, a lot of things have had to change as a result of COVID-19.
And we are aware that for some things the changes have been good, and we will probably continue them. Others have obviously been less convenient. I'm thinking obviously, of things tests like spirometry, which we've not been able to do. And some things we will have to reintroduce and work out how to do safely. So, I think it's really looking forward. COVID-19 has been a major upheaval and we're looking to the future. That is very much what I'm interested in hearing about.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More